H. Xiang

Multicenter study of the clinicopathological features and recurrence risk prediction model of early-stage breast cancer with low-positive human epidermal growth factor receptor 2 expression in China (Chinese Society of Breast Surgery 021)

Qian Wu, X. Duan, Jing-ming Ye, 2022, Chinese medical journal.

Correlation between Androgen Receptor Expression in Luminal B (HER–2 Negative) Breast Cancer and Disease Outcomes

H. Zhang, X. Duan, Qian Liu, 2022, Journal of personalized medicine.

Neoadjuvant therapy for early human epidermal growth factor receptor 2 positive breast cancer in China: A multicenter real-world study (CSBrS-015)

X. Duan, L. Xin, Yuan-jia Cheng, 2022, Chinese medical journal.

Clinicopathological analysis of early-stage breast cancer patients that meet indications for BRCA1/2 genetic testing

Ting Li, Hong Zhang, Qian Liu, 2020, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Clinicopathologic analysis of 722 breast cancer patients who met the inclusion criteria of the TAILORx trial

Ting Li, X. Duan, Hong Zhang, 2019, Chinese medical journal.

Chinese Society of Breast Surgery (CSBrS) Practice Guideline 2022

Yinhua Liu, H. Xiang, 2023, Translational breast cancer research : a journal focusing on translational research in breast cancer.

Comparison of adverse effects of anti-tumor therapy for breast cancer shortly after COVID-19 diagnosis vs. the control period

Qian Liu, Jing-ming Ye, Yuan-jia Cheng, 2023, Frontiers in Oncology.

Retrospective analysis of sentinel lymph node biopsy using methylene blue dye for early breast cancer

Shangming Yang, Ting Li, X. Duan, 2021, Chinese medical journal.

A multicenter study of the clinicopathological characteristics and a risk prediction model of early-stage breast cancer with hormone receptor-positive/human epidermal growth factor receptor 2-low expression

X. Duan, Jing-ming Ye, L. Xin, 2023, Chinese medical journal.